Ahmed Shabin

Ahmed Shabin

Auto-generated profile, based on publicly available information

Ahmed Shabin

Maldives National University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2024 in Universal Journal of Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
AIAminath Efa Ibrahim
Aminath Efa Ibrahim
FSFathimath Ina Shareef
Fathimath Ina Shareef
AYAhmed Yazdhan
Ahmed Yazdhan
ASAhmed Shabin
Ahmed Shabin
PAP. Shaik Syed Ali
P. Shaik Syed Ali
PAParwez Ahmad
Parwez Ahmad
Polycystic ovarian syndrome (PCOS) is one of the underdiagnosed endocrine disorders found to be prevalent among females in the reproductive age group. PCOS effects on an average 8-13% of reproductive aged women, globally. This condition is responsible for causing distress physiologically and psychologically paving the way for a poor quality of life. One of the devastating complications of PCOS is infertility. At present, there is no treatment for PCOS but could be managed by alternate options such as lifestyle modification to in-vitro fertilization. The primary objective of this review article is to analyze the outcomes of certain pharmacological treatment options such as clomiphene citrate which is a selective estrogen receptor modulator, Letrozole an aromatase inhibitor, and gonadotropins for PCOS-related infertility. Clomiphene citrate binds to estrogen receptors indirectly increasing the gonadotropins. Studies confirm a 35-40% successful outcome. Letrozole similarly increases gonadotropins by indirectly decreasing estrogen. A notable increase in the successful outcome was observed with both clomiphene citrate and letrozole, with almost near similar results. The pregnancy outcome was approximately 40% with clomiphene citrate, while letrozole showed 50%. Notably, more side effects were observed in the administration of clomiphene citrate compared to letrozole. Human menopausal gonadotropin (hMG) and recombinant follicle-stimulating hormone (FSHr), that are gonadotropins, were used as they are directly responsible for the maturation of follicles and ovulation itself. The use of gonadotropins increased the pregnancy rate outcome to 20 -30 %, albeit with the risk of multiple births. Furthermore, we have discussed why letrozole and clomiphene citrate are used as the primary therapy compared to gonadotropins. Peer Review History: Received 22 May 2024; Reviewed 14 July 2024; Accepted 23 August; Available online 15 September 2024 Academic Editor: Dr. Rola Jadallah, Arab American University, Palestine, rola@aauj.edu Average Peer review marks at initial stage: 5.5/10 Average Peer review marks at publication stage: 7.0/10 Reviewers: Dr. George Zhu, Tehran University of Medical Sciences, Tehran, Iran, sansan4240732@163.com Dr. Ogbonna B. Onyebuchi, Nnamdi Azikiwe University, Awka, Nigeria, summitpharm@yahoo.com

30 November 2024 in The Maldives National Journal of Research
Verified
Journal Article
Open access
PDF file
AIAminath Efa Ibrahim
Aminath Efa Ibrahim
FSFathimath Ina Shareef
Fathimath Ina Shareef
AYAhmed Yazdhan
Ahmed Yazdhan
ASAhmed Shabin
Ahmed Shabin
The declining fertility rate has been observed in the past few decades in Maldives. One of the most prevalent diseases that cause this complication is polycystic ovarian syndrome (PCOS). PCOS is a hormonal condition that has affected 13% of women in the reproductive age group globally. This is a chronic condition where various treatment options have been used to counter the complication. In this study, we analyze the effectiveness of one of the most common treatment regimens available in Maldives, letrozole, and letrozole combined with gonadotropins, for women with PCOS-related infertility.This quantitative, retrospective study analyzes data from 2019 to 2024. The population consists of women who received treatment for infertility due to PCOS at Indira Gandhi Memorial Hospital and My Clinic Private Limited, between January 1, 2019, and December 31, 2023. Our total study sample was 173 patients.Using the logistic regression model, we observed that, when compared with those who were more than 35 years, patients who were less than 25 years old, had a 9.5 times more likelihood of getting pregnant. After excluding the other variables, the odds ratio for ages less than 25 years increased from 9.5 to 13.3. Furthermore, patients who are 26 to 30 years of age show a significantly higher successful outcome when other variables are adjusted. This study shows that there is a significant relationship between age and treatment outcome of PCOS-related infertility.